☆ 4.8 Article

Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies

SCIENCE ADVANCES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemical Research Methods

InterARTIC: an interactive web application for whole-genome nanopore sequencing analysis of SARS-CoV-2 and other viruses

James M. Ferguson et al.

Summary: InterARTIC is an interactive web application that enables users to analyze viral whole-genome sequencing (WGS) data and reconstruct consensus genome sequences. It aims to facilitate widespread adoption and standardization of ONT sequencing for viral surveillance and molecular epidemiology.

BIOINFORMATICS (2022)

添加到收藏夹

Article Immunology

Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients

Lu Lu et al.

Summary: Immune sera from BNT162b2 and Coronavac recipients showed reduced neutralizing antibody titers against the omicron variant. The presence of the spike R346K mutation did not affect the neutralization susceptibility.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Review Immunology

COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies

Manuela Di Fusco et al.

Summary: A targeted literature review summarized 10 studies conducted between December 2020 and September 2021, revealing lower effectiveness of COVID-19 vaccines among immunocompromised populations compared to the general populations. It emphasizes the need for additional protective measures for immunocompromised individuals to prevent infection and associated illness.

EXPERT REVIEW OF VACCINES (2022)

添加到收藏夹

Letter Allergy

Impaired memory B-cell response to the Pfizer-BioNTech COVID-19 vaccine in patients with common variable immunodeficiency

Ane Fernandez Salinas et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Sandile Cele et al.

Summary: The study found that the Omicron variant has reduced neutralizing effectiveness in individuals vaccinated with Pfizer BNT162b2, but those who had previously been infected with SARS-CoV-2 showed better neutralization against Omicron.

NATURE (2022)

添加到收藏夹

Review Immunology

Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis

Xinhua Chen et al.

Summary: Emerging SARS-CoV-2 variants pose a threat to immunity, with varying reductions in neutralizing antibody titers. Vaccines induce neutralizing antibodies that can effectively neutralize the newer variants, but with significant reductions in neutralizing titers.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Allergy

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity

Leanne P. M. van Leeuwen et al.

Summary: This study evaluated the immune response of COVID-19 vaccines in patients with IEI. The results showed that COVID-19 vaccination was immunogenic in patients with mild antibody deficiencies and phagocyte defects, but had lower immunogenicity in patients with more severe IEI like CVID and combined B- and T-cell immunodeficiency. The presence of noninfectious complications and the use of immunosuppressive drugs negatively affected the antibody response in patients with CVID.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant

Hannes Lindahl et al.

Summary: The study describes the evolution of passive immunity to SARS-CoV-2 in commercial off-the-shelf Ig products used for IGRT during the pandemic, finding that while SARS-CoV-2 antibody concentrations in commercial Ig products increased over time, they remained inconsistently present and had reduced neutralizing capacity against the Omicron variant in batches with high concentrations of antibodies directed against the original virus strain.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

Adrian M. Shields et al.

Summary: SARS-CoV-2 vaccines show reduced immunogenicity in patients with antibody deficiency, with evidence of vaccine breakthrough infections.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

添加到收藏夹

Letter Medicine, General & Internal

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants

Jingyou Yu et al.

Summary: Although immunity from two doses of BNT162b2 vaccine diminishes over time, a booster dose significantly enhances the neutralizing antibodies against both the BA.1 and BA.2 variants.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement

Matthew McCallum et al.

Summary: The SARS-CoV-2 Omicron variant evades antibody-mediated immunity and exhibits enhanced affinity for host cells due to accumulation of spike mutations and remodeling of interactions with the ACE2 receptor.

SCIENCE (2022)

添加到收藏夹

Review Medicine, General & Internal

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis

Ainsley Ryan Yan Bin Lee et al.

Summary: This systematic review and meta-analysis compared the efficacy of covid-19 vaccines between immunocompromised and immunocompetent individuals. The results showed that immunocompromised patients, especially organ transplant recipients, had significantly lower rates of seroconversion after covid-19 vaccination. A second dose of the vaccine consistently improved seroconversion in all patient groups, although the improvement was smaller for organ transplant recipients. Targeted interventions, including a third dose (booster) of the vaccine, should be performed for immunocompromised patients.

BMJ-BRITISH MEDICAL JOURNAL (2022)

添加到收藏夹

Article Immunology

Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients

Matthijs Oyaert et al.

Summary: Immunocompromised patients may show variable immune responses to the BNT162b2 mRNA vaccine against SARS-CoV-2, and the delay in humoral or cellular immune responses depends on the patient group, therapy, and individual risk factors.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

A Moderated Mediation Model Explaining the Relationship Between Risk-Group Membership, Threat Perception, Knowledge, and Adherence to COVID-19 Behavioral Measures

Sebastian Sattler et al.

Summary: This study investigated the adherence to COVID-19 behavioral measures among vulnerable populations and found that these groups had higher perceived threat of COVID-19. Increased knowledge about COVID-19 was also associated with higher perceived threat. Risk-group membership had a positive direct effect on adherence to most behavioral measures, with those having less knowledge about COVID-19 being more likely to violate these measures. Risk-group membership also had positive indirect effects on adherence through perceived COVID-19 threat. The results suggest the importance of increasing COVID-19 knowledge and evaluating disease-regulation measures to combat the pandemic effectively.

FRONTIERS IN PUBLIC HEALTH (2022)

添加到收藏夹

Review Allergy

Immunizing the imperfect immune system Coronavirus disease 2019 vaccination in patients with inborn errors of immunity

Jessica R. Durkee-Shock et al.

Summary: This article provides an update on the immunogenicity and safety of COVID-19 vaccines in patients with IEI. The study found that most patients with IEI showed antibody responses to COVID-19 vaccination, with stronger responses observed after mRNA vaccination. While neutralizing antibodies were detected in IEI patients, the levels were consistently lower than healthy controls. Risk factors for poor antibody responses included common variable immunodeficiency, autoimmune comorbidities, and rituximab use. T cell responses were detectable in most patients with IEI, but poorer responses were often found in patients with common variable immunodeficiency. Overall, COVID-19 vaccines were safe in patients with IEI and demonstrated immunogenicity in most individuals, especially with mRNA vaccinations.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2022)

添加到收藏夹

Review Immunology

COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review

Emily Drzymalla et al.

Summary: A better understanding of COVID-19 in people with primary immunodeficiency (PI) is crucial for their protection, as they may be more prone to extended illnesses and emergence of variants. Studies have shown that some PI patients have immune response to COVID-19 vaccination, although less effective in preventing hospitalization compared to the general population. Additional strategies for PI patients' protection include pre-exposure prophylaxis and therapeutic treatments.

CLINICAL IMMUNOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Breakthrough SARS-CoV-2 infections after COVID-19 immunization

Joshua Hirsh et al.

Summary: Breakthrough infections of COVID-19 vaccines are rare, but age may still be a factor in SARS-CoV-2 infections among vaccinated individuals.

JOURNAL OF INVESTIGATIVE MEDICINE (2022)

添加到收藏夹

Letter Medicine, General & Internal

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5

Nicole P. Hachmann et al.

Summary: A small study found that omicron subvariants BA.2.12.1, BA.4, and BA.5 of SARS-CoV-2 were more likely to evade neutralizing antibodies induced by both vaccination and previous infection compared to the prior omicron subvariants BA.1 and BA.2.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease

Michaela Bitzenhofer et al.

Summary: This study aimed to evaluate the humoral immune response in patients with humoral immunodeficiency disease after receiving SARS-CoV-2 mRNA vaccines. The results showed that the antibody response was impaired to some extent in patients with immunodeficiency, especially in those with low baseline IgG levels or under immunosuppressive drug treatment.

PLOS ONE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants

Neeltje van Doremalen et al.

Summary: This study evaluates the efficacy of the AZD1222 vaccine and an updated AZD2816 vaccine against variants of concern using a Syrian hamster model. The results show that both vaccines provide protection against the Beta, Delta, and Omicron variants in the hamster model.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Immunology

IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers

Bram Decru et al.

Summary: This study investigated the kinetics of IgG anti-S and surrogate neutralizing antibodies in healthcare workers 3 and 10 months after natural infection or vaccination. The results showed that hybrid immunity resulted in the strongest immune response, and there was a linear relationship between surrogate neutralizing activity and log10 IgG anti-S.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct

Anna Z. Mykytyn et al.

Science Immunology (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses

Clarisa M. Buckner et al.

Summary: SARS-CoV-2 mRNA booster vaccines provide protection and strong immunity, but recent infection can impede B cell responses to the booster vaccines.

CELL (2022)

添加到收藏夹

Letter Medicine, General & Internal

Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa

Shirley Collie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Immunology

Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity

Daniel Leung et al.

Summary: Our study aimed to assess the safety and immunogenicity of vaccination in IEI patients in Hong Kong. The results showed that a 3-dose vaccination series can enhance the immune response in patients with humoral immunodeficiencies. In addition, immune responses were detected through cellular staining and flow cytometry.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022

Amadea Britton et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

添加到收藏夹

Article Microbiology

Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals

Brian Grunau et al.

Summary: Among vaccinated individuals, SARS-CoV-2 antibody concentrations and ACE-2 inhibition are correlated with live viral neutralizing antibody titers. Correlation is stronger in samples collected at later durations post-vaccination.

MICROBIOLOGY SPECTRUM (2022)

添加到收藏夹

Article Medicine, General & Internal

Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection

Mayan Gilboa et al.

Summary: This study found that the third dose of the vaccine provided greater durability compared to the second dose; however, Omicron showed greater resistance to neutralization compared to the wild type and Delta variants. The dynamics of humoral response were associated with susceptibility to Omicron infection.

JAMA NETWORK OPEN (2022)

添加到收藏夹

Article Cell Biology

mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes

Ofer Zimmerman et al.

Summary: Individuals with primary antibody deficiency (PAD) have poor immune responses but mRNA vaccination and boosting can provide at least short-term immunity against SARS-CoV-2 variants for these patients.

CELL REPORTS MEDICINE (2022)

添加到收藏夹

Review Rheumatology

Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis

Shintaro Akiyama et al.

Summary: Patients with autoimmune diseases have a higher risk of COVID-19, primarily due to glucocorticoid use. Monotherapy with b/tsDMARDs is associated with a lower risk of hospitalisation and death.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Article Allergy

Coronavirus disease 2019 in patients with inborn errors of immunity: An international study

Isabelle Meyts et al.

Summary: The study shows that patients with IEI exhibit varied responses to SARS-CoV-2 infection, with some requiring hospitalization and even intensive care, and a non-negligible mortality rate. In comparison to the general population, younger IEI patients may face a higher risk of severe illness and mortality.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling

Carleen Klumpp-Thomas et al.

Summary: The optimized ELISA-based serology protocol presented in this study helps define thresholds for IgG and IgM seropositivity with high specificities, minimal cross-reactivity, and flexible sample collection workflow, making it a valuable tool for standardized data generation on SARS-CoV-2 seropositivity, immunity, and infection.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Medicine, General & Internal

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

Einav G. Levin et al.

Summary: A study in Israel revealed that waning immunity after receiving two doses of the BNT162b2 vaccine led to an increase in the incidence of SARS-CoV-2 infection. Levels of spike-binding IgG and neutralizing antibodies decreased more significantly in men, individuals aged 65 or older, and immunosuppressed individuals in a longitudinal study involving nearly 4000 healthcare workers.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

Brian J. Boyarsky et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Immunology

Distinct antibody and memory B cell responses in SARS-CoV-2 naive and recovered individuals after mRNA vaccination

Rishi R. Goel et al.

Summary: mRNA vaccines exhibit robust serological and cellular priming, with naïve individuals requiring two doses for optimal antibody responses, especially against the B.1.351 variant. Memory B cells specific for spike protein and RBD were efficiently primed by vaccination, while recovered individuals showed significant boosting after the first dose, correlating with preexisting memory B cell levels. Identifying distinct responses based on prior SARS-CoV-2 exposure suggests that recovered subjects may only need one vaccine dose for peak responses, which can inform vaccine distribution strategies in resource-limited settings.

SCIENCE IMMUNOLOGY (2021)

添加到收藏夹

Article Allergy

Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity

Ottavia M. Delmonte et al.

Summary: The study evaluated antibody response and adverse events in IEI patients after COVID-19 vaccination, finding that vaccination is safe but immunogenicity is affected by certain therapies and gene defects. This data can guide counseling of IEI patients on preventing SARS-CoV-2 infection and the need for subsequent boosts.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Cell Biology

Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States

Heather Kalish et al.

Summary: The study analyzed undiagnosed SARS-CoV-2 infections in the United States and found a high prevalence rate, with different seropositivity estimates among various racial, age, gender, ethnic, and urban/rural groups. Data indicated that as of mid-July 2020, there were an estimated 16.8 million undiagnosed infections in the United States, with 4.8 undiagnosed cases for every diagnosed case of COVID-19.

SCIENCE TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Environmental Sciences

Individual and COVID-19-Specific Indicators of Compliance with Mask Use and Social Distancing: The Importance of Norms, Perceived Effectiveness, and State Response

Jordan A. Gette et al.

Summary: The study found that perceived effectiveness of safety measures was associated with personal compliance. Social norms played a role in compliance, especially in indoor settings. Increased stress, anxiety, and negative affect were linked to greater compliance, while positive affect was linked to less compliance. Non-White individuals and females were more likely to comply with protective behaviors.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history

Thomas W. McDade et al.

Summary: The two-dose mRNA vaccines against SARS-CoV-2 are effective in preventing COVID-19 infection, but there is a decline in antibody levels and reduced neutralization of emerging variants three months post-vaccination, indicating the need to identify correlates of clinical protection for booster vaccination timing and indications.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

添加到收藏夹

Article Medicine, General & Internal

Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor?

Fateme Babaha et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction

Chee Wah Tan et al.

NATURE BIOTECHNOLOGY (2020)

添加到收藏夹

Article Virology

Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2

Marina Johnson et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

添加到收藏夹

Article Immunology

The Risk and Impact of COVID-19 Pandemic on Immunosuppressed Patients: Cancer, HIV, and Solid Organ Transplant Recipients

Ali Haider Mohammed et al.

AIDS REVIEWS (2020)

添加到收藏夹

Article Biochemical Research Methods

Rapid and inexpensive whole-genome sequencing of SARS-CoV-2 using 1200 bp tiled amplicons and Oxford Nanopore Rapid Barcoding

Nikki E. Freed et al.

BIOLOGY METHODS & PROTOCOLS (2020)

添加到收藏夹

Article Statistics & Probability

Fast stable restricted maximum likelihood and marginal likelihood estimation of semiparametric generalized linear models

Simon N. Wood

JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2011)

添加到收藏夹

Article Statistics & Probability

Thin plate regression splines

SN Wood

JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2003)

添加到收藏夹

Article Statistics & Probability

Modelling and smoothing parameter estimation with multiple quadratic penalties

SN Wood

JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.